Abstract

p19, a molecule structurally related to IL-6, G-CSF, and the p35 subunit of IL-12, is a subunit of the recently discovered cytokine IL-23. Here we show that expression of p19 in multiple tissues of transgenic mice induced a striking phenotype characterized by runting, systemic inflammation, infertility, and death before 3 mo of age. Founder animals had infiltrates of lymphocytes and macrophages in skin, lung, liver, pancreas, and the digestive tract and were anemic. The serum concentrations of the proinflammatory cytokines TNF-alpha and IL-1 were elevated, and the number of circulating neutrophils was increased. In addition, ubiquitous expression of p19 resulted in constitutive expression of acute phase proteins in the liver. Surprisingly, liver-specific expression of p19 failed to reproduce any of these abnormalities, suggesting specific requirements for production of biologically active p19. Bone marrow transfer experiments showed that expression of p19 by hemopoietic cells alone recapitulated the phenotype induced by its widespread expression, pointing to hemopoietic cells as the source of biologically active p19. These findings indicate that p19 shares biological properties with IL-6, IL-12, and G-CSF and that cell-specific expression is required for its biological activity.

Highlights

  • Why The JI? Submit online. Rapid Reviews! 30 days* from submission to initial decision No Triage! Every submission reviewed by practicing scientists Fast Publication! 4 weeks from acceptance to publicatio

  • Bone marrow transfer experiments showed that expression of p19 by hemopoietic cells alone recapitulated the phenotype induced by its widespread expression, pointing to hemopoietic cells as the source of biologically active p19. These findings indicate that p19 shares biological properties with IL-6, IL-12, and G-CSF and that cell-specific expression is required for its biological activity

  • Widespread expression of p19 led to a phenotype of systemic inflammation, impaired growth, and premature death

Read more

Summary

Materials and Methods

A 0.5-kb cDNA encoding p19 was cloned as an EcoRI fragment into an expression vector containing the human CMV enhancer/chicken ␤-actin promoter and the rabbit ␤-globin polyadenylation signal [7]. The cDNA for p19 was cloned into an expression vector containing the promoter for human ␣1-antitrypsin (HAT, bp 1–1976, GenBank accession number K02212) and 145 bp of a transcriptional enhancer from the human ␣1-microglobulin/bikunin gene (bp 2163–2308) (Fig. 5A). DNA containing the transgene was resuspended in microinjection buffer to a final concentration of 1–5 ng/ml and microinjected into mouse eggs (C57BL/6J ϫ DBA/2 (B6D2) F2; The Jackson Laboratory, Bar Harbor, ME). Founders carrying the p19 gene under control of the human CMV enhancer/chicken ␤-actin promoter (Cp19) were identified by PCR amplification of a segment of the transgene using primers 5Ј-GCCCTCCTC CAGCCAGAGGAT-3Ј and 5Ј-CCAGCCACCACATTCTGATAGGCAGC CTGCAC-3Ј. As an internal control for the amplification reaction, primers for the endogenous low density lipoprotein gene were used: 5Ј-ACCCAA

Abbreviations used in this paper
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call